Search the Newsroom
Filter By
News Type
Showing 51 - 60 of 234 results
ASH 2022: CHOP Experts Presented and Contributed to More than 200 Abstracts at National Hematology Conference
Nearly 50 faculty, staff and trainees from the Division of Hematology and Division of Oncology at Children’s Hospital of Philadelphia attended the 64th Annual American Hematology Society (ASH) Meeting in New Orleans, Louisiana.
Two CHOP Researchers Named 2022 STAT Wunderkinds
Two researchers from Children’s Hospital of Philadelphia (CHOP) were recently selected by the health and science news outlet STAT as 2022 Wunderkinds, an award that celebrates the next generation of scientific superstars who are making significant contributions to biomedical research.
New Study Shows AML Ages Immune Cells, Leading to Poor Treatment Response
A new study has found that acute myeloid leukemia (AML) ages and exhausts immune cells, impairing their ability to fight off cancer.
CHOP Researchers Show Liquid Biopsies Can Catch Disease Progression Early in High-Risk Neuroblastoma
CHOP researchers found that a series of “liquid biopsies” could less invasively and more accurately identify tumor changes in patients with high-risk neuroblastoma.
CHOP Study Finds CAR T-Cell Therapy Improves Survival Regardless of Socioeconomic Status
Researchers from Children’s Hospital of Philadelphia (CHOP) have found that economically disadvantaged children treated with CAR T-cell therapy for relapsed/refractory acute lymphoblastic leukemia (ALL) fair just as well as children from more socioeconomically advantaged backgrounds.
CHOP Study Offers Proof of Concept for Treating Pediatric Brain Tumors with Immunotherapy
CHOP researchers have identified a protein on the surface of multiple pediatric brain tumors that they can target using immunotherapy in preclinical models.
2022 Parkway Run & Walk Raised Record-Breaking $2 Million for Cancer Center at Children’s Hospital of Philadelphia
Presenting Sponsor Citadel Credit Union Doubled Pledge and Renewed its Partnership for Annual Event Aimed at Conquering Childhood Cancer.
Dr. Patrick Grohar Receives Stand Up to Cancer Catalyst Award
With support from Jazz Pharmaceuticals, the grant will fund a SU2C Catalyst® Research Team led by Dr. Grohar; the team will investigate new, targeted treatments for patients 10 years and older with Ewing sarcoma.
Researchers Map Genomic Landscape of ALL
A new study by a multi-institutional group of pediatric cancer researchers, including those at CHOP, has characterized the genomic landscape for acute lymphoblastic leukemia.
FDA Approves First Potentially Curative Gene Therapy for Beta Thalassemia
A leading study site for nearly a decade, CHOP will be part of a network of treatment centers in the country offering the therapy to patients who require regular blood transfusions.